Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Lee

Showing results (601-610 of 631) with videos related to

Pageof 64
Sort By:
Science Advances|November 27, 2024
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanomaGiuseppe Tarantino, Cora A Ricker, Annette Wang, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 12, 2013
A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits with Intra-Arterial therapy (EXTEND-IA)Bruce C V Campbell, Peter J Mitchell, Bernard Yan, et al.
Nature Biotechnology|June 8, 2017
The promise of organ and tissue preservation to transform medicineSebastian Giwa, Jedediah K Lewis, Luis Alvarez, et al.
The New England Journal of Medicine|August 8, 2014
Breast-cancer risk in families with mutations in PALB2Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, et al.
Journal of the National Cancer Institute|February 29, 2020
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51DXin Yang, Honglin Song, Goska Leslie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC CarriersMarjanka K Schmidt, Frans Hogervorst, Richard van Hien, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 5, 2016
The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common CancersChristopher I Amos, Joe Dennis, Zhaoming Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2022
Cancer Risks Associated With <i>BRCA1</i> and <i>BRCA2</i> Pathogenic VariantsShuai Li, Valentina Silvestri, Goska Leslie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2019
Cancer Risks Associated With Germline <i>PALB2</i> Pathogenic Variants: An International Study of 524 FamiliesXin Yang, Goska Leslie, Alicja Doroszuk, et al.
Plos Genetics|April 2, 2013
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer riskMia M Gaudet, Karoline B Kuchenbaecker, Joseph Vijai, et al.
Pageof 64

Showing results (601-610 of 631) with videos related to

Sort By:
Pageof 64
Science Advances|November 27, 2024
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanomaGiuseppe Tarantino, Cora A Ricker, Annette Wang, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 12, 2013
A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits with Intra-Arterial therapy (EXTEND-IA)Bruce C V Campbell, Peter J Mitchell, Bernard Yan, et al.
Nature Biotechnology|June 8, 2017
The promise of organ and tissue preservation to transform medicineSebastian Giwa, Jedediah K Lewis, Luis Alvarez, et al.
The New England Journal of Medicine|August 8, 2014
Breast-cancer risk in families with mutations in PALB2Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, et al.
Journal of the National Cancer Institute|February 29, 2020
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51DXin Yang, Honglin Song, Goska Leslie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC CarriersMarjanka K Schmidt, Frans Hogervorst, Richard van Hien, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 5, 2016
The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common CancersChristopher I Amos, Joe Dennis, Zhaoming Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2022
Cancer Risks Associated With <i>BRCA1</i> and <i>BRCA2</i> Pathogenic VariantsShuai Li, Valentina Silvestri, Goska Leslie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2019
Cancer Risks Associated With Germline <i>PALB2</i> Pathogenic Variants: An International Study of 524 FamiliesXin Yang, Goska Leslie, Alicja Doroszuk, et al.
Plos Genetics|April 2, 2013
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer riskMia M Gaudet, Karoline B Kuchenbaecker, Joseph Vijai, et al.
Pageof 64